Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon/Rectal Ca”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)Study completedNCT00720785
What this trial is testing

Natural Killer Cells and Bortezomib to Treat Cancer

Who this might be right for
Chronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Ended earlyNCT01550510
What this trial is testing

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Who this might be right for
Stage IV Colorectal Cancer
Thomas Jefferson University 4
Testing effectiveness (Phase 2)Looking for participantsNCT07447050
What this trial is testing

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric (Stomach) Cancer+7 more
University of California, Irvine 24
Testing effectiveness (Phase 2)Ended earlyNCT00251186
What this trial is testing

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Who this might be right for
Colorectal Cancer
University of Medicine and Dentistry of New Jersey 18
Testing effectiveness (Phase 2)Study completedNCT00166465
What this trial is testing

Stage IV Colorectal CA ALIMTA

Who this might be right for
Locally Advanced Unresectable or Stage IV Colorectal Cancer
Mayo Clinic 200